Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancer. Hanna J, Fu MZ, Inan B, Guevara D, et al. BJUI Compass 2026;7:e70215.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hanna J, Fu MZ, Inan B, Guevara D, et al. Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancer. BJUI Compass 2026;7:e70215.
PMID: 42148429